Hardman Johnston Global Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.2M | Sell |
289,606
-27,164
| -9% | -$2.24M | 1.1% | 23 |
|
|
2025
Q4 | $27M | Sell |
316,770
-34,124
| -10% | -$2.8M | 1.29% | 22 |
|
|
2025
Q3 | $27.3M | Sell |
350,894
-60,699
| -15% | -$4.74M | 1.34% | 23 |
|
|
2025
Q2 | $32.2M | Buy |
411,593
+115,822
| +39% | +$8.64M | 1.43% | 24 |
|
|
2025
Q1 | $21.4M | Sell |
295,771
-2,315
| -0.8% | -$166K | 1.02% | 32 |
|
|
2024
Q4 | $22.1M | Sell |
298,086
-7,170
| -2% | -$502K | 0.91% | 33 |
|
|
2024
Q3 | $20.1M | Sell |
305,256
-10,315
| -3% | -$749K | 0.79% | 32 |
|
|
2024
Q2 | $29.1M | Sell |
315,571
-10,610
| -3% | -$940K | 1.13% | 27 |
|
|
2024
Q1 | $31.2M | Sell |
326,181
-1,790
| -0.5% | -$150K | 1.08% | 30 |
|
|
2023
Q4 | $25M | Sell |
327,971
-3,455
| -1% | -$240K | 0.8% | 33 |
|
|
2023
Q3 | $23M | Sell |
331,426
-3,790
| -1% | -$305K | 0.77% | 35 |
|
|
2023
Q2 | $31.6M | Sell |
335,216
-8,196
| -2% | -$712K | 1.03% | 32 |
|
|
2023
Q1 | $28.4M | Sell |
343,412
-207,316
| -38% | -$16.3M | 0.93% | 35 |
|
|
2022
Q4 | $41.1M | Sell |
550,728
-121,470
| -18% | -$9.36M | 1.61% | 21 |
|
|
2022
Q3 | $55.5M | Buy |
672,198
+65,404
| +11% | +$6.29M | 2.5% | 13 |
|
|
2022
Q2 | $57.7M | Sell |
606,794
-6,430
| -1% | -$666K | 2.45% | 10 |
|
|
2022
Q1 | $72.2M | Sell |
613,224
-57,430
| -9% | -$6.44M | 2.32% | 11 |
|
|
2021
Q4 | $86.9M | Sell |
670,654
-18,520
| -3% | -$2.16M | 2.34% | 12 |
|
|
2021
Q3 | $78M | Sell |
689,174
-55,420
| -7% | -$6.33M | 2.1% | 13 |
|
|
2021
Q2 | $77.1M | Buy |
744,594
+35,325
| +5% | +$3.33M | 1.87% | 12 |
|
|
2021
Q1 | $59.3M | Sell |
709,269
-2,360
| -0.3% | -$200K | 1.69% | 14 |
|
|
2020
Q4 | $64.9M | Sell |
711,629
-6,160
| -0.9% | -$511K | 1.88% | 11 |
|
|
2020
Q3 | $57.3M | Buy |
717,789
+41,135
| +6% | +$3.21M | 2.14% | 10 |
|
|
2020
Q2 | $46.8M | Buy |
676,654
+4,780
| +0.7% | +$340K | 2.06% | 13 |
|
|
2020
Q1 | $42.2M | Buy |
671,874
+4,140
| +0.6% | +$299K | 2.46% | 12 |
|
|
2019
Q4 | $51.9M | Sell |
667,734
-31,824
| -5% | -$2.48M | 2.1% | 14 |
|
|
2019
Q3 | $51.3M | Sell |
699,558
-128,220
| -15% | -$9.01M | 2.35% | 12 |
|
|
2019
Q2 | $51M | Sell |
827,778
-60,420
| -7% | -$3.65M | 2.26% | 12 |
|
|
2019
Q1 | $56.6M | Sell |
888,198
-82,875
| -9% | -$4.73M | 2.49% | 10 |
|
|
2018
Q4 | $49.6M | Sell |
971,073
-55,500
| -5% | -$2.81M | 2.57% | 10 |
|
|
2018
Q3 | $59.6M | Sell |
1,026,573
-13,560
| -1% | -$663K | 2.57% | 9 |
|
|
2018
Q2 | $50.5M | Sell |
1,040,133
-81,390
| -7% | -$3.8M | 2.13% | 9 |
|
|
2018
Q1 | $52.2M | Sell |
1,121,523
-15,330
| -1% | -$666K | 2.22% | 8 |
|
|
2017
Q4 | $42.7M | Sell |
1,136,853
-4,560
| -0.4% | -$167K | 1.81% | 15 |
|
|
2017
Q3 | $41.6M | Buy |
1,141,413
+3,360
| +0.3% | +$128K | 1.77% | 14 |
|
|
2017
Q2 | $44.9M | Buy |
1,138,053
+122,550
| +12% | +$4.47M | 1.94% | 9 |
|
|
2017
Q1 | $31.8M | Sell |
1,015,503
-1,626
| -0.2% | -$50.9K | 1.43% | 18 |
|
|
2016
Q4 | $31.8M | Sell |
1,017,129
-8,733
| -0.9% | -$283K | 1.55% | 17 |
|
|
2016
Q3 | $41.2M | Sell |
1,025,862
-55,164
| -5% | -$2.08M | 1.88% | 11 |
|
|
2016
Q2 | $35.9M | Sell |
1,081,026
-23,610
| -2% | -$808K | 1.83% | 12 |
|
|
2016
Q1 | $32.5M | Buy |
1,104,636
+10,446
| +1% | +$288K | 1.91% | 13 |
|
|
2015
Q4 | $28.8M | Buy |
1,094,190
+87,750
| +9% | +$2.28M | 1.91% | 16 |
|
|
2015
Q3 | $23.8M | Buy |
1,006,440
+73,920
| +8% | +$1.78M | 1.59% | 22 |
|
|
2015
Q2 | $22.1M | Sell |
932,520
-21,480
| -2% | -$485K | 1.33% | 27 |
|
|
2015
Q1 | $22.7M | Buy |
954,000
+1,620
| +0.2% | +$36.3K | 1.37% | 27 |
|
|
2014
Q4 | $20.2M | Sell |
952,380
-42,000
| -4% | -$844K | 1.09% | 35 |
|
|
2014
Q3 | $16.9M | Sell |
994,380
-9,540
| -1% | -$151K | 0.94% | 36 |
|
|
2014
Q2 | $14.4M | Buy |
1,003,920
+12,840
| +1% | +$174K | 0.77% | 41 |
|
|
2014
Q1 | $12.3M | Buy |
991,080
+28,722
| +3% | +$331K | 0.72% | 44 |
|
|
2013
Q4 | $10.5M | Buy |
962,358
+264,840
| +38% | +$2.99M | 0.69% | 45 |
|
|
2013
Q3 | $8.1M | Buy |
697,518
+1,260
| +0.2% | +$14.7K | 0.54% | 46 |
|
|
2013
Q2 | $7.8M | Buy |
+696,258
| New | +$8.24M | 0.53% | 45 |
|
Other funds holding EW
VCM
VPM
Hardman Johnston Global Advisors's EW Position: Q1 2026 in Review
Hardman Johnston Global Advisors reduced its Edwards Lifesciences (EW) stake by 8.6% in Q1 2026, selling an estimated $2.24M and leaving 289,606 shares worth $23.2M. The position accounts for 1.1% of the portfolio, ranked #23.
Hardman Johnston Global Advisors first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $86.9M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Hardman Johnston Global Advisors held 289,606 shares of Edwards Lifesciences worth $23.2M as of Q1 2026.
- Hardman Johnston Global Advisors sold 27,164 Edwards Lifesciences shares in Q1 2026, an estimated $2.24M.
- Edwards Lifesciences made up 1.1% of Hardman Johnston Global Advisors's portfolio in Q1 2026, its #23 holding.
- Hardman Johnston Global Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Hardman Johnston Global Advisors's Edwards Lifesciences position peaked at $86.9M in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Hardman Johnston Global Advisors's 13F filing for Q1 2026, filed 13 May 2026.